Investor Relations: Voting rights announcement » Vita 34

Vita 34 AG, 24.08.2017 / 17:55 Dissemination of a Voting Rights Announcement transmitted by DGAP – a service of EQS Group AG. The issuer is solely responsible for the content of this announcement.

Mr Michael Köhler and MK Beleggingsmaatschappij Venlo B.V. informed us on 22 August 2017 according to Article 27a Section 1 of the WpHG about his objectives for the acquisition of voting rights and the origin of the funds used for the acquisition after exceeding the 10% threshold on 04 August 2017:

The investment serves as a long-term strategic commitment more than the attainment of commercial profits.
The acquisition of further shares and thus further voting rights is intended, provided that the value develops positively.
There is no intention to exercise stronger influence on appointments to the issuer’s administrative, management and supervisory bodies.
There is no intention to seek a significant change in the company’s capital structure, particularly with regard to the relationship of equity, external financing and the dividend policy.
Regarding the origin of the funds used, this is exclusively our own funds.

24.08.2017 The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases. Archive at www.dgap.de,

Language:	English
Company:	Vita 34 AG
	Deutscher Platz 5a
	04103 Leipzig
	Germany
Internet:	www.vita34.de


End of News	DGAP News Service

Vita 34 AG: Release according to Article 26, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution

Michael , Köhler, 28 Dec 1962

Vita 34 AG: Release according to Article 26, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution

Mr Michael Köhler

Vita 34 AG: Release according to Article 26, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution

Mr Dr. Eberhard Lampeter

Vita 34 AG: Release according to Article 26, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution

Mr Dr. Eberhard Lampeter

Vita 34 AG: Release according to Article 26, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution

Mr Dr. Johann Hansmann

Vita 34 AG: Release according to Article 26, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution

Human Stem Cells Institute PJSC, Moscow, Russian Federation

Vita 34 AG: Release according to Article 26, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution

On August 03, 2015, Dr. Holger Födisch, Germany, has informed us according to Article 21, Section 1 of

Vita 34 AG: Release according to Article 26, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution

On March 31, 2015, the Landesbank Baden-Württemberg, Stuttgart, Germany, has informed us in accordance

Vita 34 AG: Publication according to § 26 paragraph. 1 WpHG with the objective of Europe-wide distribution

On March 03, 2015, Axxion S.A., Grevenmacher, Luxembourg has informed us according to Article 21, Section

Vita 34 AG: Publication according to § 26 paragraph. 1 WpHG with the objective of Europe-wide distribution

On February 26, 2015, the Landesbank Baden-Württemberg, Stuttgart, Germany, has informed us in accordance

Vita 34 AG: Publication according to § 26 paragraph. 1 WpHG with the objective of Europe-wide distribution

Notification of voting rights pursuant to Art. 25, Sec. 1 WpHG We received the following notification

Vita 34 AG: Publication according to § 26 paragraph. 1 WpHG with the objective of Europe-wide distribution

On January 14, 2015, Human Stem Cells Institute OJSC, Moscow, Russia has informed us according to Article

Vita 34 AG: Publication according to § 26 paragraph. 1 WpHG with the objective of Europe-wide distribution

On June 20, 2014, HSCI OJSC, Moscow, Russia has informed us according to Article 21, Section 1 of the

Vita 34 AG: Publication according to § 26 paragraph. 1 WpHG with the objective of Europe-wide distribution

On May 30, 2014, SBF Sächsische Beteiligungsfonds GmbH, Leipzig, Germany has informed us according to

Correction of a release from 27.01.2014, 20:05 CET – Vita 34 AG: Release according to Article 26, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution

On January 23, 2014, the Landesbank Baden-Württemberg, Stuttgart, Germany, has informed us in accordance

Vita 34 AG: Release according to Article 26, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution

On January 23, 2014, the Landesbank Baden-Württemberg, Stuttgart, Germany, has informed us in accordance

Vita 34 AG: Publication according to § 26 paragraph. 1 WpHG with the objective of Europe-wide distribution

Nob Hill GmbH, Berlin, Germany has informed us according to Article 21, Section 1 of the WpHG that via

Publication according to § 26 paragraph. 1 WpHG and Correction of a release from 12.09.2012, 17:10 CET – VITA 34 AG: Release according to Article 26, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution

Publication in accordance with Article 26 Section 1 of the WpHG. The Nob Hill GmbH, Berlin, Germany,

Publication according to § 26 Paragraph. 1 WpHG and Correction of a release from 07.09.2012, 19:25 CET – VITA 34 AG: Release according to Article 26, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution

Publication in accordance with Article 26 Section 1 of the WpGH The Nob Hill GmbH, Berlin, Germany has

Publication according to § 26 paragraphe. 1 WpHG and Correction of a release, 04.09.2012, 09:40 CET – VITA 34 AG: Release acc. to Art. 26, Sec. 1 of the WpHG with the objective of Europe-wide distribution – Correction of the voting rights announcement …

Publication in accordance with Article 26 Section 1 of the WpHG The Nob Hill GmbH, Berlin, Germany,

Publication according to § 26 paragraph. 1 WpHG and Correction of a release from 15.03.2012, 17:24 CET – VITA 34 AG: Release according to Article 26, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution

Publication in accordance with Article 26 Section 1 of the WpHG The Nob Hill GmbH, Berlin, Germany,

Vita 34 AG: Publication according to § 26 paragraph. 1 WpHG with the objective of Europe-wide distribution

On January 21, 2014, SBF Sächsische Beteiligungsfonds GmbH, Leipzig, Germany has informed us according

Vita 34 AG: Correction of the notification of voting rights as of 22.11.2013 – Release according to Article 26, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution

On November 22, 2013, Human Stem Cells Institute OJSC (HSCI), Moscow, Russia has informed us according

Vita 34 AG: Publication according to § 26 paragraph. 1 WpHG with the objective of Europe-wide distribution

On November 22, 2013, HSCI OJSC, Moscow, Russia has informed us according to Article 21, Section 1 of

Vita 34 AG: Publication according to § 26 paragraph. 1 WpHG with the objective of Europe-wide distribution

On November 19, 2013, Elvaston Partners GmbH, Berlin, Germany has informed us according to Article 21,

Vita 34 AG: Publication according to § 26 paragraph. 1 WpHG with the objective of Europe-wide distribution

On November 19, 2013, Mr Oliver Thum, United Kingdom has informed us according to Article 21, Section

VITA 34 AG: Release according to Article 26, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution

HSCI OJSC, Moscow, Russia, has informed us in accordance with Section 21 para. 1 of the WpHG, that its

VITA 34 AG: Release according to Article 26, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution

Elvaston Partners GmbH, Berlin, Germany, has informed us in accordance with Section 21 para. 1 of the

VITA 34 AG: Release according to Article 26, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution

Elvaston Partners GmbH, Berlin, Germany, has informed us in accordance with Section 21 para. 1 of the

VITA 34 AG: Release according to Article 26, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution – Correction of the voting rights announcement of August 30, 2012

Correction of the voting rights announcement of August 30, 2012 Elvaston Partners GmbH, Berlin, Germany,

VITA 34 AG: Release according to Article 26, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution – Correction of the voting rights announcement of August 29, 2012

Correction of the voting rights announcement of August 29, 2012 Landesbank Baden-Württemberg, Stuttgart,

VITA 34 AG: Release according to Article 26, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution

Elvaston Partners GmbH, Berlin, Germany, has informed us in accordance with Section 21 para. 1 of the

VITA 34 AG: Release according to Article 26, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution

Landesbank Baden-Württemberg, Stuttgart, Germany, has informed us in accordance with Section 21 para.

VITA 34 AG: Release according to Article 26, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution – Correction of the voting rights announcement of August 27, 2012

Correction of the voting rights announcement of August 27, 2012 Dr. André Gerth, Germany, has informed

VITA 34 AG: Release according to Article 26, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution

Publicationof a NotificationpursuanttoSection 27aGerman Securities Trading Act (WpHG) – On 23 August

VITA 34 AG: Release according to Article 26, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution

Dr. André Gerth, Germany, has informed us in accordance with Article 21 Section 1 of the WpHG, that via

VITA 34 AG: Release according to Article 26, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution

VITA 34 AG, Leipzig, Germany, herewith voluntarily notifies pursuant to Section 26 para. 1 sentence 2

VITA 34 AG: Release according to Article 26, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution

Publication in accordance with Article 26 Section 1 of the WpHG with the objective of a Europe-wide distribution

VITA 34 AG: Release according to Article 26, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution

Publication in accordance with Article 26 Section 1 of the WpHG The Independence Blue Cross, Philadelphia,

VITA 34 AG: Release according to Article 26, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution

Publication in accordance with § 26 section 1 WpHG The Landesbank Baden-Württemberg, Stuttgart, Germany,

VITA 34 AG: Release according to Article 26, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution

Mr. Dr. Holger Födisch, Germany, has informed us in accordance with § 21 section 1 WpHG, that his share

VITA 34 International AG: Release according to Article 26, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution

VITA 34 International AG, Leipzig, Germany announces pursuant to section 26 (1) sentence 2 WpHG voluntarily

VITA 34 International AG: Release according to Article 26, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution

1. On 17 May 2010 Novel Pharma, SL, Alcala de Henares (Madrid), Spain, has informed us pursuant to section

VITA 34 International AG: Release according to Article 26, Section 1 of the WpHG [the German Securities Trading Act]

Mr. Dr. Uwe Marx, Germany, has informed us in accordance with § 21 section 1 WpHG, that his share percentage

VITA 34 International AG: Release according to Article 26, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution

The Sachsen Finanzgruppe, Leipzig, Germany, has informed us in accordance with § 21 section 1 WpHG, that

Vita 34 International AG: Release according to Article 26, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution

The Landesbank Baden-Württemberg, Stuttgart, Germany, has informed us in accordance with § 21 section

Vita 34 International AG: Release according to Article 26, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution

The Secuvita SL, Madrid, Spain, has informed us in accordance with § 21 section 1 WpHG, that her share

Vita 34 International AG: Release according to Article 26, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution

The Sachsen LB, Leipzig, Germany, has informed us in accordance with § 21 section 1 WpHG, that her share

Vita 34 International AG: Release according to article 26, section 1 WpHG [Securities Trading Act] with the aim of a Europe-wide distribution

The Sachsen LB, Leipzig, Germany, has informed us in accordance with § 21 section 1a WpHG, that her share

Vita 34 International AG: Release according to article 26, section 1 WpHG [Securities Trading Act] with the aim of a Europe-wide distribution

Dr. Eberhard F. Lampeter, Leipzig, Germany, has informed us in accordance with § 21 section 1a WpHG,